AcuDart tests are some of the most accurate tests on the market for tick-borne illnesses. With a sensitivity greater than 90%, they are far superior to either the common two-tier Lyme testing from large commercial laboratories, or other at-home options.
However, AcuDart tests may not always give you all of the information that you need. For example, AcuDart tests will not report on IgM vs IgG antibodies. IgM antibodies develop first, and are a good indicator of active disease. IgG antibodies develop after a couple of months, and can indicate long term or chronic disease. Knowing this information can be helpful for determining next steps.
Additionally, AcuDart tests will not determine which species triggered an antibody response. Even though our Lyme disease test detects antibodies to nine different species, the test result will not disclose which of those species is responsible for the response. Knowing species-level information can help with targeted treatments.
Below are some guidelines on what you can do based on your AcuDart test results. For more information, please contact your healthcare provider.